Dapiglutide clinical trials
Also written ZP7570.
- studies test it
- 5
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How each study uses dapiglutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
5 studies that test it; most in 2023 (2)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 1
Zealand Pharma (4) · University Hospital, Gentofte, Copenhagen (1)
Studies
Open first, then newest update. How each study uses dapiglutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 5
- A Trial Comparing Pharmacokinetics, Safety and Tolerability of Two Subcutaneous Concentrations of DapiglutideCompletedPhase 1Zealand PharmaNCT06758583Written as Dapiglutide 7.5 mg
- A Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570TerminatedPhase 1Zealand PharmaNCT06000891Written as ZP7570
- Dapiglutide for the Treatment of ObesityActive, not recruitingPhase 2University Hospital, Gentofte, CopenhagenNCT05788601Written as Dapiglutide
- A Multiple Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570CompletedEarly Phase 1Zealand PharmaNCT04612517Written as ZP7570
- A Single Ascending Dose Trial Assessing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZP7570CompletedEarly Phase 1Zealand PharmaNCT03994549Written as Dual GLP-1/GLP-2 Receptor agonists
Codes
What other systems call dapiglutide · ClinicalTrials.gg INT016907
- UNII (FDA) J43GMI6IYWDAPIGLUTIDEOne source FDA
- NCI Thesaurus C175764DapiglutideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | J43GMI6IYW | DAPIGLUTIDE | One source FDA |
| NCI Thesaurus | C175764 | Dapiglutide | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.